Publications by authors named "Robert Rotche"

Claim this Profile
I
Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate.
Caio M Rocha Lima, Mark R Green, Robert Rotche, Wilson H Miller, G Mark Jeffrey

J Clin Oncolยท September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis